Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Workday
WDAY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
INCY Incyte
- 62.660
- +2.230+3.69%
Close Apr 30 16:00 ET
- 62.000
- -0.660-1.05%
Post 20:01 ET
12.13BMarket Cap313.30P/E (TTM)
62.870High59.760Low2.82MVolume60.950Open60.430Pre Close174.95MTurnover1.75%Turnover Ratio417.73P/E (Static)193.57MShares83.95052wk High3.31P/B10.11BFloat Cap52.81052wk Low--Dividend TTM161.42MShs Float153.150Historical High--Div YieldTTM5.15%Amplitude1.850Historical Low61.986Avg Price1Lot Size
Incyte News
Incyte | 10-Q: Q1 2025 Earnings Report
Incyte | 8-K: Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | 10-K: FY2024 Annual Report
Incyte | 8-K: Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance and Highlights 2025 R&D Milestones
Incyte | 10-Q: Q3 2024 Earnings Report
Incyte | 8-K: Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | 10-Q: Q2 2024 Earnings Report
Incyte | 8-K: Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | 10-Q: Q1 2024 Earnings Report
Incyte | 8-K: Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | 10-K/A: Annual report (Amendment)
Incyte | 10-K: FY2023 Annual Report
Incyte | 8-K: Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Incyte | 10-Q: Q3 2023 Earnings Report
Incyte | 8-K: Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | 10-Q: Q2 2023 Earnings Report
Incyte | 8-K: Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | 10-Q: Q1 2023 Earnings Report
Incyte | 8-K: Incyte Reports 2023 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Incyte | 10-K: FY2022 Annual Report
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
